MediPharm Labs (MEDIF) has recently reported an agreement with a relevant cannabis player. Besides, the company has received new financing to continue developing its new facilities in Australia. Despite the good news, the company is very undervalued as compared to peers. The share price is at $4.57, and the recent developments justify a stock price of $7.
Business
Founded in 2015, MediPharm Labs Corp. is a licensed Canadian producer of cannabis oil under the Access to Cannabis for Medical Purposes Regulations. The company focuses on the production of cannabis oil purchased from licensed cultivators and